Yvonne Chen

Prof. Chen’s research experience includes engineering RNA-based regulatory systems for mammalian systems, demonstrating the ability to achieve rapid, reversible, small-molecule–responsive control over T-cell proliferation in tissue culture and in animal models. As a postdoctoral scholar at the Seattle Children’s Research Institute and Harvard Medical School, Yvonne continued her research on engineering next-generation chimeric antigen receptors capable of logical computation of multiple antigen signals to enhance adoptive T-cell therapy for cancer. Yvonne was a Junior Fellow at the Harvard Society of Fellows and a recipient of the 2012 NIH Director’s Early Independence Award.